AstraZeneca PLC Stock Forecast for 2023 - 2025 - 2030

Updated on 11/29/2023

Stock Rating
17
Price Target
£164.51
Consensus
Outperform
Upside
66.17%
Analysts
4
Stock Rating
17
Upside
66.17%
Analysts
4
Price Target
£164.51

AstraZeneca PLC Stock Forecast and Price Target

AstraZeneca PLC has an average price target of £164.51 recently offered by four notable experts for 2023, which would represent a potential upside of approximately 66.17% from the last closing price in November, 2023 if reached. This potential increase is based on a high estimate of £212.90 and a low estimate of £135.10. If you're looking to buy AstraZeneca PLC stock, you may also want to check out its rivals.

£164.51

66.17% Upside

Buy
Buy

AstraZeneca PLC Fair Value Forecast for 2023 - 2025 - 2030

AstraZeneca PLC's Price has grown in the last three years, jumping from £60.73 to £115.55 – an increase of 90.29%. In the next year, analysts predict that Fair Value will reach £126.66 – an increase of 9.61%. For the next eight years, the forecast is for Fair Value to grow by 94.89%.

2023 Fair Value Forecast
£126.66
2024 Fair Value Forecast
£140.54
2025 Fair Value Forecast
£164.30
2026 Fair Value Forecast
£184.78
2027 Fair Value Forecast
£200.39
2028 Fair Value Forecast
£202.65
2029 Fair Value Forecast
£216.18
2030 Fair Value Forecast
£225.20
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LLY Stock Forecast Eli Lilly & Co Outperform 16
$591.60 Buy/Sell $594.01 9.87%
NOVO B Stock Forecast Novo Nordisk A/S Outperform 10
kr687.90 Buy/Sell kr696.07 12.30%
JNJ Stock Forecast Johnson & Johnson Outperform 10
$151.63 Buy/Sell $176.14 13.43%
MRK Stock Forecast Merck Outperform 5
$100.18 Buy/Sell $123.75 24.78%
ABBV Stock Forecast AbbVie Outperform 10
$138.08 Buy/Sell $167.35 20.94%

AstraZeneca PLC Revenue Forecast for 2023 - 2025 - 2030

AstraZeneca PLC's Revenue has grown in the last three years, jumping from £24.38B to £44.35B – an increase of 81.89%. In the next year, analysts predict that Revenue will reach £45.76B – an increase of 3.17%. For the next eight years, the forecast is for Revenue to grow by 46.60%.

2023 Rev Forecast
£45.76B
2024 Rev Forecast
£50.38B
2025 Rev Forecast
£54.30B
2026 Rev Forecast
£57.57B
2027 Rev Forecast
£60.03B
2028 Rev Forecast
£61.51B
2029 Rev Forecast
£63.76B
2030 Rev Forecast
£65.02B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
NOVN Stock Forecast Novartis Outperform 9
CHF86.00 Buy/Sell CHF103.75 17.87%
ABT Stock Forecast Abbott Laboratories Outperform 10
$102.06 Buy/Sell $116.25 12.97%
AMGN Stock Forecast Amgen Inc Outperform 7
$265.52 Buy/Sell $275.75 8.09%

AstraZeneca PLC Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, AstraZeneca PLC's Dividend per Share has increased by 3.57%, going from £2.80 to £2.90. In the next year, analysts are expecting an increase in Dividend per Share, predicting it will reach £3.01 – an increase of 3.79%. The AstraZeneca PLC forecast is for Dividend per Share to reach £5.28 or grow by 82.07%.

2023 DPS Forecast
£3.01
2024 DPS Forecast
£3.16
2025 DPS Forecast
£3.29
2026 DPS Forecast
£3.48
2027 DPS Forecast
£3.70
2028 DPS Forecast
£4.26
2029 DPS Forecast
£5.03
2030 DPS Forecast
£5.28
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MDT Stock Forecast Medtronic PLC Outperform 11
$78.63 Buy/Sell $90.05 14.46%
BMY Stock Forecast Bristol-Myers Squibb Co Outperform 2
$48.92 Buy/Sell $64.26 25.72%
GILD Stock Forecast Gilead Sciences Inc Outperform 11
$74.51 Buy/Sell $87.30 21.46%

AstraZeneca PLC Free Cash Flow Forecast for 2023 - 2025 - 2030

AstraZeneca PLC's Free Cash Flow has increased by 338.04% In the last three years, going from £1.99B to £8.72B. According to 2 analysts, AstraZeneca PLC's Free Cash Flow will fall by 33.17% in the next year, reaching £5.83B. For the next eight years, the forecast is for Free Cash Flow to grow by 169.81%.

2023 FCF Forecast
£5.83B
2024 FCF Forecast
£9.94B
2025 FCF Forecast
£12.75B
2026 FCF Forecast
£14.22B
2027 FCF Forecast
£15.93B
2028 FCF Forecast
£20.14B
2029 FCF Forecast
£21.48B
2030 FCF Forecast
£23.52B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CSL Stock Forecast CSL Buy 12
$256.88 Buy/Sell $207.22 -20.64%
MRK Stock Forecast Merck KGaA Buy 17
157.80€ Buy/Sell 204.63€ 18.19%
GSK Stock Forecast GSK Outperform 12
£14.12 Buy/Sell £17.30 14.73%

AstraZeneca PLC Net Income Forecast for 2023 - 2025 - 2030

In the last three years, AstraZeneca PLC's Net Income has grown, increasing from £1.34B to £3.29B – an increase of 146.29%. For next year, the 15 analysts predict Net Income of £11.35B, which would mean an increase of 245.32%. Over the next eight years, the pros' prediction is Net Incomeof £19.77B, which would mean a eight-year growth forecast of 501.33%.

2023 NI Forecast
£11.35B
2024 NI Forecast
£13.10B
2025 NI Forecast
£14.95B
2026 NI Forecast
£16.16B
2027 NI Forecast
£17.41B
2028 NI Forecast
£17.96B
2029 NI Forecast
£19.04B
2030 NI Forecast
£19.77B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BDX Stock Forecast Becton Dickinson and Co Outperform 9
$237.28 Buy/Sell $301.27 22.22%
MMM Stock Forecast 3M Co Hold 10
$98.51 Buy/Sell $110.96 8.62%
4568 Stock Forecast Daiichi Sankyo Company Outperform 18
¥4.06k Buy/Sell ¥0.00 25.74%

AstraZeneca PLC EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, AstraZeneca PLC's EBITDA has grown, increasing from £5.65B to £13.90B – a growth of 146.06%. The next year looks promising for AstraZeneca PLC, with analysts predicting EBITDA of £15.34B – an increase of 10.39%. Over the next eight years, experts anticipate that AstraZeneca PLC's EBITDA will grow at a rate of 61.73%.

2023 EBITDA Forecast
£15.34B
2024 EBITDA Forecast
£18.11B
2025 EBITDA Forecast
£20.15B
2026 EBITDA Forecast
£22.10B
2027 EBITDA Forecast
£23.81B
2028 EBITDA Forecast
£21.56B
2029 EBITDA Forecast
£22.12B
2030 EBITDA Forecast
£22.47B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BAS Stock Forecast BASF Hold 11
42.71€ Buy/Sell 48.98€ 10.04%
LONN Stock Forecast Lonza Group Outperform 16
CHF351.70 Buy/Sell CHF756.46 45.44%
4519 Stock Forecast Chugai Pharmaceutical Outperform 18
¥4.94k Buy/Sell ¥0.00 3.24%

AstraZeneca PLC EBIT Forecast for 2023 - 2025 - 2030

In the last three years, AstraZeneca PLC's EBIT has grown by 186.72%, from £3.13B to £8.96B. For the next year, analysts are expecting EBIT to reach £14.95B – an increase of 66.79%. Over the next eight years, experts predict that EBIT will grow by 194.32%.

2023 EBIT Forecast
£14.95B
2024 EBIT Forecast
£17.26B
2025 EBIT Forecast
£19.48B
2026 EBIT Forecast
£21.05B
2027 EBIT Forecast
£22.76B
2028 EBIT Forecast
£23.83B
2029 EBIT Forecast
£25.36B
2030 EBIT Forecast
£26.38B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BAYN Stock Forecast Bayer Outperform 7
30.56€ Buy/Sell 55.86€ 60.34%
BIIB Stock Forecast Biogen Inc Outperform 11
$227.41 Buy/Sell $322.44 36.76%
CTVA Stock Forecast Corteva Outperform 12
$45.50 Buy/Sell $59.82 30.77%

AstraZeneca PLC EPS Price Prediction Forecast for 2023 - 2025 - 2030

AstraZeneca PLC's EPS has grown in the last three years, jumping from £3.50 to £6.66 – an increase of 90.29%. In the next year, analysts predict that EPS will reach £7.30 – an increase of 9.61%. For the next eight years, the forecast is for EPS to grow by 94.89%.

2023 EPS Forecast
£7.30
2024 EPS Forecast
£8.10
2025 EPS Forecast
£9.47
2026 EPS Forecast
£10.65
2027 EPS Forecast
£11.55
2028 EPS Forecast
£11.68
2029 EPS Forecast
£12.46
2030 EPS Forecast
£12.98
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MRNA Stock Forecast Moderna Outperform 11
$78.18 Buy/Sell $182.39 63.09%
BNTX Stock Forecast BioNTech Outperform 12
$98.30 Buy/Sell $201.43 7.79%
BGNE Stock Forecast BeiGene Buy 6
$184.84 Buy/Sell $0.00 55.27%